A password will be e-mailed to you.

LEAMINGTON, ON ,  Jan. 10, 2018  /CNW/ – Aphria Inc. (“Aphria” or the “Company“) (TSX: APH or USOTCQB:  APHQF) today reported its results, for the second quarter ended  November 30 , 2017.  All amounts are expressed in thousands of Canadian dollars. We closed the quarter with strong top-line gains – revenue and Kilograms sold reached record highs and we moved closer to our increased our production capacity expectations,” said Vic Neufeld, CEO of Aphria. “With a growing product mix and patient base from both new and exsiting clients, we continue to affirm our positon as a strong Canadian market leader as we remain focused on executing our strategy to drive sustainable growth and shareholder value. Looking ahead, we continue to explore strategic opportunities and partnerships to extend the Aphria brand and our product offerings in both the medical and adult-use marketplace. Aphria Q2 Sales Grow 39% to $8.5 Million

thumbnail courtesy of newcannabisventures.com